In human estrogen receptor negative (ER-) breast cancer cells (MDA-MB-231) EDME was found to reduce migration and invasion, corroborating the efficacy of these compounds to interfere with cancer hallmarks in a TRPML1-dependent but estrogen receptor independent manner. Here, MCOLN1 is linked to breast carcinoma.